ArticleCardiovascular diabetology2016

A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.

Lung-Sheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.